The Media is Wrong About Glucosamine-Chondroitin
You’ve probably seen headlines on TV and in newspapers, saying a big new government test of glucosamine-chondroitin found the pain-killers “ineffective” and no better than a placebo.
Don’t believe it. It’s far from true. The fact is a combination of glucosamine and chondroitin was incredibly effective in reducing osteoarthritis pain in those to whom it matters most–those who suffer moderate to severe pain, as we reported in a newsflash last October. In fact, glucosamine-chondroitin was 50% more effective than a placebo and 14% more effective than the common drug Celebrex at relieving moderate to severe knee pain in people with osteoarthritis!
This finding that a natural substance beat the costly prescription drug, Celebrex, was an unpleasant surprise to the pharmaceutical industry, says Jason Theodosakis, M.D., a leading arthritis expert, and a member of a committee for the National Institutes of Health, overseeing the study.
Now, the study has been published in The New England Journal of Medicine, and press releases that distort the conclusions in favor of Celebrex, and contain partial truths have been widely picked up by the media. Here’s how it works: The headlines now say glucosamine-chondroitin did not relieve “mild” osteoarthritic knee pain, and Celebrex did. And since most people in the study had only “mild” pain, glucosamine-chondroitin didn’t work for most people.
True–but in cases of “moderate to serious” pain, glucosamine-chondroitin did work and Celebrex did not! Something you might want to know! No doctor should prescribe Celebrex anyway for “mild” pain says Dr. Theodosakis, because of its serious side effects. He says glucosamine-chondroitin was an amazing success.